Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Unaudited)

v3.22.4
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Jan. 31, 2023
Oct. 31, 2022
Current assets:    
Cash and cash equivalents $ 9,790 $ 12,360
Short-term investments 17,912 17,327
Receivables 147 47
Prepaid expenses and other current assets 256 466
Total current assets 28,105 30,200
Operating lease right-of-use asset 201 212
Total assets 28,306 30,412
Current liabilities:    
Accounts payable 110 265
Accrued expenses 1,075 1,726
Operating lease liability 47 46
Total current liabilities 1,232 2,037
Operating lease liability, non-current 162 175
Total liabilities 1,394 2,212
Commitments and contingencies (Note 10)
Shareholders’ equity:    
Preferred stock
Common stock, par value $.01 per share; 100,000,000 shares authorized; 30,922,830 and 30,913,902 shares issued and outstanding as of January 31, 2023 and October 31, 2022, respectively 309 309
Additional paid-in capital 248,189 247,123
Accumulated deficit (220,707) (218,385)
Total shareholders’ equity 27,791 29,047
Noncontrolling interest (Note 2) (879) (847)
Total equity 26,912 28,200
Total liabilities and equity 28,306 30,412
Series A Convertible Preferred Stock [Member]    
Shareholders’ equity:    
Preferred stock